Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for May 14, 2010 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Eidogen-Sertanty Offers Academic Version of Kinase Database
Eidogen-Sertanty, Inc. announced the release of an academic version of their popular Kinase Knowledgebase (KKB). This version is available to academics for online purchase at www.kinasedata.com. 
x-small text small text medium text large text


Hot Kinase TargetsHot Kinase Targets
Eidogen-Sertanty's Kinase Knowledgebase contains high quality data on targets of clinical interest
    SAN DIEGO, CA, May 14, 2010 /24-7PressRelease/ -- Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, today announced the release of an academic version of its popular Kinase Knowledgebase (KKB). This version is available to academic researchers for online purchase at www.kinasedata.com.

The Kinase Knowledgebase (KKB) is Eidogen-Sertanty's database of structure-activity relationship (SAR) and chemical synthesis data focused on protein kinases. The KKB is released quarterly and currently contains over 500,000 data points curated from over 6,200 peer-reviewed journal articles and patents.

Eidogen-Sertanty will be making datasets for QSAR and modeling available for online purchase also at www.kinasedata.com. These will contain data covering high-quality concentration response end points of biochemical assays aggregated by unique chemical structures across assay protocols and unique HUGO kinase targets. The aggregated data can be used directly to develop QSAR or categorization models.

For more information, please contact:

Steve Muskal
760-651-2885
pr@eidogen-sertanty.com

Eidogen-Sertanty is a privately-held company dedicated to helping scientists discover new medicines with innovative software technology and knowledgebases. To find out more about Eidogen-Sertanty please visit www.eidogen-sertanty.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Steven Muskal:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Steven Muskal
Eidogen-Sertanty

CEO
3460 Marron Rd Ste 103-475
Oceanside, CA
USA 92056
Voice: 760-651-2885
Fax: 760-775-822-1721
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.